Technology in pharma and healthcare from Pharma Journal: AI in drug discovery, digital health, data platforms and the tools transforming research and clinical practice. How emerging technology reshapes how medicines are found, developed and delivered.
The MHRA has granted first-in-world approval for belantamab mafodotin combination regimens in relapsed myeloma, supported by landmark DREAMM-7 and DREAMM-8 Phase 3 trial data.
By Megan Liu, Digital Health Reporter
Microgravity is increasingly recognised as a valuable tool for antimicrobial discovery due to its impact on microbial interactions, competition, and adaptation. Evidence from the International Space S
By Dr. Eleanor Vance, Regulatory Affairs Editor
The first regulatory approvals for a CRISPR-based medicine in the UK and EU marked a turning point for genomic medicine and set expectations for oncology. In 2023, the MHRA licensed exagamglogene auto
By Dr. Eleanor Vance, Regulatory Affairs Editor
Cathepsin B (CTSB) is a lysosomal cysteine protease that plays a key role in protein turnover, antigen processing, and immune regulation. It is widely expressed across mammalian tissues. Recent resear
By Dr. Eleanor Vance, Regulatory Affairs Editor
Chronic illness drives demand across the NHS and shapes budgets, workforce planning and service design. People living with multiple long-term conditions account for around half of hospital admissions,
By Dr. Eleanor Vance, Regulatory Affairs Editor
For patients living with blood cancer or a severe blood disorder, a stem cell transplant is often the turning point between decline and recovery. Yet for years in the UK, the calendar has been the ene
By Dr. Eleanor Vance, Regulatory Affairs Editor
Human gene editing sits at a pivotal point in modern medicine. Its capacity to change DNA with precision has moved from conjecture to clinical practice, raising hopes for curative treatments while ign
By Dr. Eleanor Vance, Regulatory Affairs Editor
Artificial intelligence is moving from pilot projects to practical tools across the NHS. The policy direction is clear, with a shift to community-based care and a focus on prevention, personalisation
By Megan Liu, Digital Health Reporter
The rise of online pharmacy services has redrawn the UK medicines landscape in less than a decade. Digital ordering, remote prescribing, and courier fulfilment now sit alongside the community pharmacy
By Megan Liu, Digital Health Reporter
]In today’s fast-evolving healthcare and pharmaceutical industries, precision and reliability are non-negotiable. From hospitals and research laboratories to biotech companies and pharmaceutical manuf
By Megan Liu, Digital Health Reporter
Prolapse describes structural descent caused by failure of regular anatomical support. Pelvic organ prolapse is an organ herniation into or beyond the vagina driven by weakness in the muscles, fascia
By Megan Liu, Digital Health Reporter
Huntington's disease remains without a cure in 2025. Clinical practice focuses on symptom control while a new wave of molecular programmes seeks to slow or halt neurodegeneration. The evidence base po
By Dr. Eleanor Vance, Regulatory Affairs Editor
Five years after the acute waves of COVID-19, Long COVID has settled into public health planning as a common post-infectious condition with sustained clinical, economic and social effects. The term de
By Dr. Eleanor Vance, Regulatory Affairs Editor
Subscribe to our weekly pharmaceutical intelligence digest
We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy